Published in Psychother Psychosom Med Psychol on November 01, 1998
[From diagnosis to group therapy. A professional comment on Tschuschke et al.: Psychotherapy research--how it should (not) be done]. Psychother Psychosom Med Psychol (1998) 1.39
Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (1997) 5.40
Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70
[Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides]. Biomed Biochim Acta (1984) 2.80
Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell (2000) 2.77
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Polypeptide flux through bacterial Hsp70: DnaK cooperates with trigger factor in chaperoning nascent chains. Cell (1999) 2.33
Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol (1998) 2.21
Catalysis of protein folding by prolyl isomerase. Nature (1987) 2.21
Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med (1999) 2.14
Characterization of cspB, a Bacillus subtilis inducible cold shock gene affecting cell viability at low temperatures. J Bacteriol (1992) 2.04
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet (2000) 2.02
A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics (1999) 2.00
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry (1998) 1.80
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. EMBO J (1995) 1.79
The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta (1985) 1.75
Nonprolyl cis peptide bonds in unfolded proteins cause complex folding kinetics. Nat Struct Biol (2001) 1.74
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
The L2/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions. J Cell Biol (1988) 1.67
Treatment of opioid dependence in pregnant women. Addiction (2000) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur J Biochem (1990) 1.60
Enzymes that catalyse the restructuring of proteins. Curr Opin Struct Biol (2000) 1.58
Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett (1994) 1.56
Catalysis of protein folding by cyclophilins from different species. J Biol Chem (1991) 1.56
Neurite outgrowth patterns in cerebellar microexplant cultures are affected by antibodies to the cell surface glycoprotein L1. J Neurosci (1986) 1.55
Cooperation of enzymatic and chaperone functions of trigger factor in the catalysis of protein folding. EMBO J (1997) 1.49
Continuous spinal anesthesia versus continuous femoral nerve block for elective total knee replacement. Minerva Anestesiol (2011) 1.48
A selective imaging of tinnitus. Neuroreport (1999) 1.44
Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect Immun (1995) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
[Satisfaction with inpatient management. Development of a questionnaire and initial validity studies]. Psychother Psychosom Med Psychol (1989) 1.41
Giant cephalhaematoma in a 17-year-old boy with Ehlers-Danlos syndrome. Br J Neurosurg (1998) 1.39
A revision of Pheidole Westwood (Hymenoptera: Formicidae) in the islands of the southwest Indian Ocean and designation of a neotype for the invasive Pheidole megacephala. Zootaxa (2013) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
The unstable region of Streptomyces ambofaciens includes 210 kb terminal inverted repeats flanking the extremities of the linear chromosomal DNA. Mol Microbiol (1996) 1.37
Immunophilins: structure-function relationship and possible role in microbial pathogenicity. Mol Microbiol (1993) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure (1997) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Dynamic MRI scan plane control for passive tracking of instruments and devices. Med Image Comput Comput Assist Interv (2007) 1.32
Conformational specificity of chymotrypsin toward proline-containing substrates. Biochim Biophys Acta (1984) 1.32
Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother (2009) 1.31
Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat Struct Biol (2001) 1.31
Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet (1981) 1.29
A novel peptidyl-prolyl cis/trans isomerase from Escherichia coli. FEBS Lett (1994) 1.28
The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe Seylers Z Physiol Chem (1975) 1.26
Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry (1998) 1.24
Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol (1997) 1.22
Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae. J Biol Chem (1999) 1.22
Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry (1989) 1.22
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy. Biochemistry (1995) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Differential effects of DNA-binding proteins on bidirectional transcription from the common promoter region of human collagen type IV genes COL4A1 and COL4A2. Biochim Biophys Acta (1993) 1.19
Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics (2000) 1.16
Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Anticancer Res (1997) 1.15
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant (2002) 1.14
The Escherichia coli SlyD is a metal ion-regulated peptidyl-prolyl cis/trans-isomerase. J Biol Chem (1997) 1.14
Natural distribution of 5 bacteria associated with periodontal disease. J Clin Periodontol (1993) 1.14
[Development and short-term effects of a standardized patient education program for in-patient cardiologic rehabilitation]. Rehabilitation (Stuttg) (2013) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Chest wall and intrathoracic desmoid tumors: surgical experience and review of the literature. Eur J Med Res (2009) 1.13
Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther (2002) 1.13
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood (2000) 1.12
The activator of cerebroside-sulphatase. A model of the activation. Biochim Biophys Acta (1978) 1.10
FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer. Eur J Surg Oncol (2006) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet (1992) 1.07
[Angiosarcoma of the heart]. Dtsch Med Wochenschr (1970) 1.06
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion (2000) 1.06
Intermediate filament typing of the human embryonic and fetal notochord. Cell Tissue Res (1995) 1.05
An 11.8 kDa proteolytic fragment of the E. coli trigger factor represents the domain carrying the peptidyl-prolyl cis/trans isomerase activity. FEBS Lett (1996) 1.05
Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol (2001) 1.05
Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. J Med Chem (1999) 1.05
A school-based strategy to assess children's environmental exposures and related health effects in economically disadvantaged urban neighborhoods. J Expo Anal Environ Epidemiol (2001) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci (2001) 1.04
Classification of severity of health problems in family/general practice: an international field trial. Fam Pract (1996) 1.03
The influence of steric and electronic parameters on the substrate behavior of -oxo acids to yeast pyruvate decarboxylase. Eur J Biochem (1973) 1.03
First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites. J Invest Dermatol (1998) 1.03
Comparative mutational analysis of peptidyl prolyl cis/trans isomerases: active sites of Escherichia coli trigger factor and human FKBP12. FEBS Lett (1997) 1.02
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology (1990) 1.02
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Dimyelia, diplomyelia, and diastematomyelia. Clin Neuropathol (1982) 1.01
Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut (1988) 1.01
Isolation and amino acid sequence of a new 22-kDa FKBP-like peptidyl-prolyl cis/trans-isomerase of Escherichia coli. Similarity to Mip-like proteins of pathogenic bacteria. J Biol Chem (1996) 1.00
Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase. FEBS Lett (1999) 1.00
Evidence for genetic heterogeneity in Best's vitelliform macular dystrophy. J Med Genet (1995) 1.00
NMR solution structure of hPar14 reveals similarity to the peptidyl prolyl cis/trans isomerase domain of the mitotic regulator hPin1 but indicates a different functionality of the protein. J Mol Biol (2000) 1.00
Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection. Mult Scler (2007) 1.00